Precision Autoimmune Therapeutics
Beijing
About Precision Autoimmune Therapeutics
Precision Autoimmune Therapeutics is a clinical-stage innovative drug development company focused on precision therapeutics for patients with autoimmune and inflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $20.9M
- Last round: Series Unknown (Jul 2022)
Industries & Categories
Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/precision-autoimmune-therapeutics-159551 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.